Intraoperative Dexamethasone in Pediatric Cardiac Surgery
Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Perioperative administration of steroids has been demonstrated to reduce systemic
inflammatory response in infants undergoing cardiac surgery with cardiopulmonary bypass.
However, data on effects of steroids on clinical outcomes are lacking. Hence the hypothesis
of the present study: intraoperative administration of dexamethasone reduces complication
rates and improves clinical outcomes in infants undergoing repair of congenital heart defects
under cardiopulmonary bypass.
Phase:
Phase 3
Details
Lead Sponsor:
Meshalkin Research Institute of Pathology of Circulation